Miguel Divo is a Respiratory physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 139 publications with 6,291 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Pulmonary Division Brigham And Women'S Hospital
Boston, MA 021156110
Telephone
857-307-0310Registry record last updated 7 Jun 2012.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI US SERVICES INC.Program year20251 payment
- Gyrus ACMI, Inc.Program year20252 payments
- Gyrus ACMI, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
77.7%Corticosteroid52.7%Trelegy Ellipta47%Breo Ellipta32%Breztri Aerosphere21%Part D<11 patientsAnticholinergic9.8%Incruse Ellipta100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
12.9%Macrolide Antimicrobial12.9%Azithromycin100%Part D≥12 patientsMetabolism & gastrointestinal
9.4%Corticosteroid9.4%Prednisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement
American Journal of Respiratory and Critical Care Medicine
2024 - Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine
2024 - COPD and multimorbidity: recognising and addressing a syndemic occurrence
The Lancet Respiratory Medicine
2023 - From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
European Respiratory Journal
2023 - Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”